Crossref
journal-article
Elsevier BV
Cancer Cell (78)
References
52
Referenced
149
10.1038/sj.onc.1205015
/ Oncogene / The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells by Baptiste (2002)10.1074/jbc.M008879200
/ J. Biol. Chem. / A role for the polyproline domain of p53 in its regulation by Mdm2 by Berger (2001)10.1016/j.cell.2004.11.022
/ Cell / A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans by Bond (2004)10.1038/sj.onc.1202281
/ Oncogene / Comparative study of the p53-mdm2 and p53-MDMX interfaces by Bottger (1999)10.4161/cc.3.7.997
/ Cell Cycle / Dynamics in the p53-Mdm2 ubiquitination pathway by Brooks (2004)10.1074/jbc.M306938200
/ J. Biol. Chem. / Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses by Chao (2003){'key': '10.1016/j.ccr.2006.03.014_bib7', 'first-page': '8664', 'article-title': 'Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets', 'volume': '63', 'author': 'Chavez-Reyes', 'year': '2003', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets by Chavez-Reyes (2003)10.1038/sj.emboj.7600812
/ EMBO J. / ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage by Chen (2005)10.1126/science.1092734
/ Science / Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis by Chipuk (2004)10.1128/MCB.24.13.5835-5843.2004
/ Mol. Cell. Biol. / Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity by Danovi (2004)10.1038/356215a0
/ Nature / Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours by Donehower (1992)10.1128/MCB.23.23.8846-8861.2003
/ Mol. Cell. Biol. / The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53 by Dornan (2003)10.1042/0264-6021:3590459
/ Biochem. J. / Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover by Dumaz (2001)10.1038/sj.onc.1206726
/ Oncogene / The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions by Edwards (2003){'key': '10.1016/j.ccr.2006.03.014_bib15', 'first-page': '3221', 'article-title': 'mdmx is a negative regulator of p53 activity in vivo', 'volume': '62', 'author': 'Finch', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / mdmx is a negative regulator of p53 activity in vivo by Finch (2002)10.1073/pnas.0508476103
/ Proc. Natl. Acad. Sci. USA / Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo by Francoz (2006)10.1074/jbc.C200150200
/ J. Biol. Chem. / Mutual dependence of MDM2 and MDMX in their functional inactivation of p53 by Gu (2002)10.1038/sj.onc.1202282
/ Oncogene / Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation by Hengstermann (1998)10.4161/cc.4.6.1696
/ Cell Cycle / p53QS: an old mutant teaches us new tricks by Johnson (2005)10.1038/378206a0
/ Nature / Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 by Jones (1995)10.1074/jbc.M308295200
/ J. Biol. Chem. / DNA damage-induced MDMX degradation is mediated by MDM2 by Kawai (2003)10.1073/pnas.0503068102
/ Proc. Natl. Acad. Sci. USA / The C-terminal lysines fine-tune p53 stress responses in a mouse model, but are not required for stability control or transactivation by Krummel (2005)10.1073/pnas.210171597
/ Proc. Natl. Acad. Sci. USA / Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study by Lev Bar-Or (2000)10.1073/pnas.2030930100
/ Proc. Natl. Acad. Sci. USA / HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 by Linares (2003)10.1038/ng1282
/ Nat. Genet. / Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice by Liu (2004)10.1016/0092-8674(93)90719-7
/ Cell / p53-dependent apoptosis modulates the cytotoxicity of anticancer agents by Lowe (1993)10.4161/cc.3.7.999
/ Cell Cycle / KeePin' the p53 family in good shape by Mantovani (2004)10.1016/j.bbrc.2005.03.151
/ Biochem. Biophys. Res. Commun. / Mdmx as an essential regulator of p53 activity by Marine (2005)10.1073/pnas.0334477100
/ Proc. Natl. Acad. Sci. USA / Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation by McCoy (2003)10.1016/j.molcel.2005.04.024
/ Mol. Cell / Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2 by Meulmeester (2005)10.1128/MCB.22.15.5527-5538.2002
/ Mol. Cell. Biol. / Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development by Migliorini (2002)10.1038/sj.cdd.4400736
/ Cell Death Differ. / Neuronal life and death: an essential role for the p53 family by Miller (2000)10.1038/378203a0
/ Nature / Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 by Montes de Oca Luna (1995)10.1038/sj.onc.1208354
/ Oncogene / p53 must be competent for transcriptional regulation to suppress tumor formation by Nister (2005)10.1073/pnas.94.26.14602
/ Proc. Natl. Acad. Sci. USA / Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells by O'Gorman (1997)10.1128/MCB.25.21.9608-9620.2005
/ Mol. Cell. Biol. / DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation by Okamoto (2005)10.1038/ng714
/ Nat. Genet. / Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 by Parant (2001)10.1073/pnas.0408595102
/ Proc. Natl. Acad. Sci. USA / Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage by Pereg (2005)10.1073/pnas.0408744102
/ Proc. Natl. Acad. Sci. USA / The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development by Ren (2005)10.1038/sj.onc.1203500
/ Oncogene / Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain by Roth (2000)10.1038/sj.onc.1201263
/ Oncogene / The polyproline region of p53 is required to activate apoptosis but not growth arrest by Sakamuro (1997)10.1038/sj.onc.1206925
/ Oncogene / Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth by Steinman (2004)10.1038/sj.onc.1208930
/ Oncogene / Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development by Steinman (2005)10.1038/sj.emboj.7600145
/ EMBO J. / Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation by Stommel (2004)10.1016/j.cell.2004.06.004
/ Cell / Yin Yang 1 is a negative regulator of p53 by Sui (2004)10.1126/science.1092472
/ Science / In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 by Vassilev (2004)10.1093/emboj/17.16.4668
/ EMBO J. / The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression by Venot (1998)10.1038/nrc864
/ Nat. Rev. Cancer / Live or let die: the cell's response to p53 by Vousden (2002){'key': '10.1016/j.ccr.2006.03.014_bib49', 'series-title': '25 Years of p53 Research', 'first-page': '73', 'article-title': 'Gatekeepers of the guardian: p53 regulation by post-translational modification, mdm2 and mdmx', 'author': 'Wahl', 'year': '2005'}
/ 25 Years of p53 Research / Gatekeepers of the guardian: p53 regulation by post-translational modification, mdm2 and mdmx by Wahl (2005)10.1073/pnas.93.26.15335
/ Proc. Natl. Acad. Sci. USA / Identification of a novel p53 functional domain that is necessary for efficient growth suppression by Walker (1996)10.1073/pnas.0508500103
/ Proc. Natl. Acad. Sci. USA / Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development by Xiong (2006)10.1038/sj.onc.1202533
/ Oncogene / Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity by Zhu (1999)
Dates
Type | When |
---|---|
Created | 19 years, 4 months ago (April 11, 2006, 12:44 p.m.) |
Deposited | 6 years, 7 months ago (Jan. 17, 2019, 12:50 a.m.) |
Indexed | 1 month ago (July 31, 2025, 11:47 p.m.) |
Issued | 19 years, 5 months ago (April 1, 2006) |
Published | 19 years, 5 months ago (April 1, 2006) |
Published Print | 19 years, 5 months ago (April 1, 2006) |
@article{Toledo_2006, title={A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network}, volume={9}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/j.ccr.2006.03.014}, DOI={10.1016/j.ccr.2006.03.014}, number={4}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Toledo, Franck and Krummel, Kurt A. and Lee, Crystal J. and Liu, Chung-Wen and Rodewald, Luo-Wei and Tang, Mengjia and Wahl, Geoffrey M.}, year={2006}, month=apr, pages={273–285} }